Madam Speaker, as we have seen over the decades, a number of trade agreements have gutted our manufacturing base in Canada and refocused us on exporting raw materials, such as raw bitumen and raw logs. We are seeing this problem right now with vaccines and the lack of pharmaceutical capacity in this country. We used to have a lot of capacity for this. We used to be a leader in vaccine manufacturing and providing vaccines around the world.
What does the hon. member think we should be focusing on here? Have we had the wrong focus? Should we be doing more on the value-added side and less exporting of raw materials? As we are seeing with the death of a pipeline—